XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.

Teladoc shares hit record low after telehealth firm withdraws 2024 forecast



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Teladoc shares hit record low after telehealth firm withdraws 2024 forecast</title></head><body>

Adds share milestone in paragraph 1, background in paragraph 3 and graphics

By Bhanvi Satija

Aug 1 (Reuters) -Teladoc Health's TDOC.N shares hit a record low on Thursday, as surging costs and declining revenue in its mental health services unit forced the virtual healthcare provider to withdraw its annual and long-term forecasts.

The company recorded a $790 million impairment charge related to BetterHelp in the second quarter and flagged a double-digit increase in customer acquisition expenses from last quarter.

Teladoc enjoyed several years of growth, further accelerated by a surge in demand for virtual medical services during the pandemic as the lockdowns forced people to stay indoors.

The company is now undergoing what some analysts called a "strategic reset" under the leadership of its recently hired CEO Chuck Divita.

"Teladoc has become a victim of its own success and finds itself at a crossroads as it explores the next phase of growth," Oppenheimer analyst Michael Wiederhorn said.

Higher advertising costs for BetterHelp have also hampered the telehealth provider's growth in the United States.

Integrated Care, Teladoc's chronic care unit, should be the focus of its strategic shift, Leerink Partners analyst Michael Cherny wrote in a note titled 'BetterHelp Needs Some Help'.

BetterHelp services are offered directly to consumers on its platform and through some partnerships with employer groups.

Teladoc said on Wednesday it was assessing if it can offer services for the platform through more contracts with health insurers and employer groups.

While expanding BetterHelp's products and international presence are viable options, a potential sale of the segment can also be a path forward, said Barclays analyst Stephanie Davis.

Shares of Teladoc tumbled 13% to $8.22 in morning trading.

At least five brokerages cut their price targets on Teladoc stock. It has declined about 60% so far in 2024 and is on track to post a fall for the fourth straight year.


Teladoc's annual sales grew during the pandemic https://reut.rs/3A14D7C

Teladoc share performance since 2019 https://reut.rs/3Yod5bl


Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar

</body></html>

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.